Joseph Michael Reardon (Joseph M Reardon)

Years Active: 2019-2022
Publications (10 Years): 3

Vanderbilt University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Medical Center Jul 01 2016 - Jun 30 2018

United States

International Emergency Medicine Fellow :: Emergency Medicine

Publications

Mohamad Shebley, Stanley Wang, Izna Ali, Preethi Krishnan, Rakesh Tripathi, Joseph Michael Reardon, John Cafardi, Galia Rahav, Yoseph Caraco, Jihad Slim, Fadi Al Akhrass, Mengjia Yu, Yiran Hu, Rosa De Abreu Ferreira, Negar N Alami
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19. Pharmacology research & perspectives 11 (1) (2022)
Mohamad Shebley, Stanley Wang, Izna Ali, Preethi Krishnan, Rakesh Tripathi, Joseph Michael Reardon, John Cafardi, Galia Rahav, Yoseph Caraco, Jihad Slim, Fadi Al Akhrass, Mengjia Yu, Yiran Hu, Rosa De Abreu Ferreira, Negar N Alami
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19. Pharmacology research & perspectives 11 (1) (2022)
Joseph Michael Reardon, Siobhán M O'Connor, Joseph D Njau, Eugene K Lam, Catherine A Staton, Susan T Cookson
Cost-effectiveness of birth-dose hepatitis B vaccination among refugee populations in the African region: a series of case studies. Conflict and health 13 (2019)

Joseph Michael Reardon.css-eqlu8i{font-size:small;padding-left:4px;} (Joseph M Reardon)